Tg Therapeutics
1 known investors
TG Therapeutics is a biopharmaceutical company developing and marketing treatments for relapsing forms of multiple sclerosis. Its FDA-approved therapy BRIUMVI (ublituximab) is an anti-CD20 monoclonal antibody administered by infusion for adults with relapsing MS.
Biotech
Investors · 1
Frequently asked questions
- What does Tg Therapeutics do?
- TG Therapeutics is a biopharmaceutical company developing and marketing treatments for relapsing forms of multiple sclerosis. Its FDA-approved therapy BRIUMVI (ublituximab) is an anti-CD20 monoclonal antibody administered by infusion for adults with relapsing MS.
- Who are Tg Therapeutics's investors?
- Tg Therapeutics's investors include HEALTHCARE ROYALTY PARTNERS.